Microbial Strain Typing for Epidemiology and Infection Control (English)
- New search for: Leber, Amy L.
In:
Clinical Microbiology Procedures Handbook
;
13.5.1-13.5.7
;
2016
-
ISBN:
- Article/Chapter (Book) / Electronic Resource
-
Title:Microbial Strain Typing for Epidemiology and Infection Control
-
Contributors:Leber, Amy L. ( editor )
-
Published in:Clinical Microbiology Procedures Handbook ; 13.5.1-13.5.7
-
Publisher:
- New search for: ASM Press
-
Place of publication:Washington, DC, USA
-
Publication date:2016-05-15
-
Size:7 pages
-
ISBN:
-
DOI:
-
Type of media:Article/Chapter (Book)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents eBook
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1.1
-
Index| 2016
- 1.1.1
-
Introduction| 2016
- 1.2.1
-
Procedure Coding, Reimbursement, and Billing Compliance| 2016
- 2.1.1
-
Collection, Transport, and Manipulation of Clinical Specimens and Initial Laboratory Concerns| 2016
- 3.2.1.1
-
Staining Procedures| 2016
- 3.3.1.1
-
Processing, Isolation, Detection, and Interpretation of Aerobic Bacteriology Cultures| 2016
- 3.4.1.1
-
Blood Cultures| 2016
- 3.5.1
-
Body Fluid Cultures (Excluding Blood, Cerebrospinal Fluid, and Urine)| 2016
- 3.6.1
-
Diagnosis of Catheter‐Related Bloodstream Infection: Differential‐Time‐to‐Positivity Cultures and Catheter Tip Cultures| 2016
- 3.7.1
-
Cerebrospinal Fluid Cultures| 2016
- 3.8.1.1
-
Fecal and Other Gastrointestinal Cultures and Toxin Assays| 2016
- 3.9.1.1
-
Genital Cultures| 2016
- 3.10.1
-
Ocular Cultures| 2016
- 3.11.1.1
-
Respiratory Tract Cultures| 2016
- 3.12.1
-
Urine Cultures| 2016
- 3.13.1.1
-
Wound Cultures| 2016
- 3.14.1
-
Leptospira Culture| 2016
- 3.15.1.1
-
Detection of Human Mycoplasmas and Ureaplasmas from Clinical Specimens by Culture and PCR| 2016
- 3.16.1
-
Guidelines for Biochemical Identification of Aerobic Bacteria| 2016
- 3.17.1.1
-
Biochemical Tests for the Identification of Aerobic Bacteria| 2016
- 3.18.1.1
-
Identification of Gram‐Positive Bacteria| 2016
- 4.2.1
-
Collection, Transport, and Processing of Clinical Specimens for Anaerobic Culture| 2016
- 4.3.1
-
Culture Media for Anaerobes| 2016
- 4.4.1
-
Incubation Techniques for Anaerobic Bacteriology Specimens| 2016
- 4.5.1
-
Examination of Primary Culture Plates for Anaerobic Bacteria| 2016
- 4.6.1.1
-
Rapid Disk, Spot Tests, and Other Rapid or Primary Methods for the Identification of Anaerobes| 2016
- 4.7.1
-
Commercial Kit Overnight Biochemical Systems for the Identification of Anaerobes| 2016
- 4.8.1
-
Rapid Enzymatic Systems for the Identification of Anaerobes| 2016
- 4.9.1.1
-
Rapid Biochemical Tests (4 Hours or Less) for the Identification of Anaerobes| 2016
- 4.10.1
-
Use of Matrix‐Assisted Laser Desorption Ionization–Time of Flight for the Identification of Anaerobic Bacteria| 2016
- 4.11.1
-
Anaerobic Gram‐Negative Bacilli| 2016
- 4.12.1
-
Anaerobic Gram‐Positive Bacilli| 2016
- 4.13.1
-
Anaerobic Cocci| 2016
- 4.14.1
-
Suggestions for a Practical Scheme for the Workup of Anaerobic Cultures| 2016
- 4.15.1
-
Clostridium difficile as a Pathogen Involved in Antimicrobial Agent‐Associated Diarrhea, Colitis, and Pseudomembranous Colitis| 2016
- 5.1.1
-
Disk Diffusion Test| 2016
- 5.2.1.1
-
Broth Microdilution Test| 2016
- 5.3.1
-
Etest| 2016
- 5.4.1.1
-
Agar Dilution MIC Test| 2016
- 5.5.1
-
Beta‐Lactamase Tests| 2016
- 5.6.1
-
Oxacillin Salt‐Agar Screen Test To Detect Oxacillin (Methicillin)‐Resistant Staphylococcus aureus| 2016
- 5.7.1
-
Detection of VRSA, VISA, and Vancomycin‐Heteroresistant Staphylococcus aureus (hVISA)| 2016
- 5.8.1
-
Screening Tests for Detection of High‐Level Mupirocin Resistance in Staphylococcus aureus| 2016
- 5.9.1
-
Detection of Inducible Clindamycin Resistance in Staphylococcus spp., Streptococcus pneumoniae, and Streptococcus spp. Beta‐Hemolytic Group| 2016
- 5.10.1
-
Screen Tests To Detect High‐Level Aminoglycoside Resistance in Enterococcus spp.| 2016
- 5.11.1
-
Agar Screen Test To Detect Vancomycin Resistance in Enterococcus spp.| 2016
- 5.12.1
-
Extended‐Spectrum Beta‐Lactamase Testing for Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis| 2016
- 5.13.1
-
The Modified Hodge Confirmatory Test (or the Carbapenem Inactivation Test) for Carbapenemase Production in Enterobacteriaceae| 2016
- 5.14.1.1
-
Minimum Bactericidal Concentration Testing| 2016
- 5.15.1
-
Serum Inhibitory and Bactericidal Titers| 2016
- 5.16.1
-
Synergism Testing: Broth Microdilution Checkerboard and Broth Macrodilution Methods| 2016
- 5.17.1
-
Quality Assurance Measures for Antimicrobial Susceptibility Testing| 2016
- 5.18.1
-
Evaluation and Verification of Antimicrobial Susceptibility Test Systems| 2016
- 5.19.1
-
Selecting Antimicrobial Agents for Testing and Reporting| 2016
- 5.20.1.1
-
Preparation of Routine Media and Reagents Used in Antimicrobial Susceptibility Testing| 2016
- 5.21.1
-
Preparation of Broth Microdilution MIC Trays| 2016
- 5.22.1.1
-
Appendixes| 2016
- 6.2.1
-
Specimen Examination and Primary Isolation| 2016
- 6.3.1
-
Media and Methods Used for Phenotypic Characterization of Aerobic Actinomycetes| 2016
- 6.4.1
-
Molecular Identification| 2016
- 6.5.1
-
Susceptibility Testing| 2016
- 7.2.1.1
-
General Mycobacterial Procedures| 2016
- 7.3.1
-
Solid Media Used for Isolation| 2016
- 7.4.1.1
-
Liquid Media Used for Isolation| 2016
- 7.5.1.1
-
Identification of Mycobacteria| 2016
- 7.6.1.1
-
Nucleic Acid Amplification Procedures for Identification from Specimen| 2016
- 7.7.1.1
-
Susceptibility Testing by Liquid Media Methods| 2016
- 7.8.1
-
Susceptibility Testing by Agar Proportion Method for Mycobacterium tuberculosis Complex| 2016
- 7.9.1.1
-
Susceptibility Testing by TREK Sensititre Microdilution Plates| 2016
- 8.1.1
-
Introduction and General Considerations| 2016
- 8.2.1
-
Specimen Selection, Collection, and Transport| 2016
- 8.3.1.1
-
Specimen Examination| 2016
- 8.4.1
-
Processing Specimens for Fungal Culture| 2016
- 8.5.1
-
Examination and Evaluation of Primary Cultures| 2016
- 8.6.1
-
Presumptive Identification Tests for Yeasts Isolated on Primary Culture| 2016
- 8.7.1
-
Identification of Moulds on Primary Culture| 2016
- 8.8.1
-
Full Identification of Yeasts| 2016
- 8.9.1
-
Mould Identification| 2016
- 8.10.1.1
-
Antifungal Susceptibility Testing| 2016
- 9.2.1
-
Collection and Preservation of Fecal Specimens| 2016
- 9.3.1.1
-
Macroscopic and Microscopic Examination of Fecal Specimens| 2016
- 9.4.1.1
-
Special Stains for Coccidia and Microsporidia| 2016
- 9.5.1.1
-
Additional Techniques for Stool Examination| 2016
- 9.6.1.1
-
Other Specimens from the Intestinal Tract and the Urogenital System| 2016
- 9.7.1.1
-
Sputum, Aspirates, and Biopsy Material| 2016
- 9.8.1.1
-
Detection of Blood Parasites| 2016
- 9.9.1.1
-
Culture| 2016
- 9.10.1.1
-
Appendix 9.10.1–1—Identification Aids: Artifacts| 2016
- 10.1.1
-
Laboratory Diagnosis of Viral Infections: Introduction| 2016
- 10.2.1
-
Selection, Maintenance, and Observation of Uninoculated Monolayer Cell Cultures| 2016
- 10.3.1
-
Cell Culture Techniques: Serial Propagation and Maintenance of Monolayer Cell Cultures| 2016
- 10.4.1
-
Specimen Collection and Processing| 2016
- 10.5.1
-
Viral Culture: Isolation of Viruses in Cell Cultures| 2016
- 10.6.1
-
Isolation of Chlamydia spp. in Cell Culture| 2016
- 10.7.1
-
Direct Detection of Viruses and Chlamydia in Clinical Samples| 2016
- 11.1.1.1
-
Immunology Introduction| 2016
- 11.2.1.1
-
Serologic Diagnosis of Group A Streptococcal Infections| 2016
- 11.3.1
-
Detection of Legionella Antigen by Direct Immunofluorescence| 2016
- 11.4.1.1
-
Laboratory Diagnosis of Syphilis| 2016
- 11.5.1
-
Detection of Borrelia burgdorferi Antibodies| 2016
- 11.6.1.1
-
Serodiagnosis of Rickettsial Infections| 2016
- 11.7.1
-
Virology Introduction| 2016
- 11.8.1.1
-
Human Immunodeficiency Virus Serology| 2016
- 11.9.1.1
-
Epstein‐Barr Virus| 2016
- 11.10.1.1
-
Cytomegalovirus Serology| 2016
- 11.11.1.1
-
Herpes Simplex Virus 1 and 2 Serology| 2016
- 11.12.1.1
-
Flow Cytometry| 2016
- 11.13.1.1
-
Whole‐Blood Lymphocyte Immunophenotyping Using Cell Surface Markers by Flow Cytometry| 2016
- 11.14.1.1
-
Natural Killer Cell Assays| 2016
- 11.15.1.1
-
Dendritic Cell Assays| 2016
- 11.16.1.1
-
Neutrophil Assays| 2016
- 11.17.1.1
-
Peripheral Blood Mononuclear Cells| 2016
- 11.18.1
-
Lymphocyte Proliferation Assay| 2016
- 11.19.1.1
-
Measurement of Antigen‐Specific Cellular Responses Using the Polychromatic Flow Cytometry Intracellular Cytokine Staining Assay| 2016
- 11.20.1
-
Interferon Gamma Enzyme‐Linked Immunosorbent Spot Assay| 2016
- 11.21.1.1
-
Bead‐ and Plate‐Based Cytokine Enzyme‐Linked Immunosorbent Assays| 2016
- 12.2.1.1
-
General Aspects of Molecular Diagnostics| 2016
- 12.3.1.1
-
Molecular Methods for Identification of Cultured Microorganisms| 2016
- 12.4.1.1
-
Sequence‐Based Identification and Typing| 2016
- 12.5.1
-
Matrix‐Assisted Laser Desorption Ionization Time of Flight (MALDITOF) for Microorganism Identification| 2016
- 12.6.1
-
Appendix 12.6–1—FDA‐Cleared or Approved Nucleic Acid‐Based Tests| 2016
- 12.7.1
-
Appendix 12.7–1—Location in CMPH4 of Molecular Procedures Outside of Section 12| 2016
- 13.2.1
-
Laboratory Support for Infection Prevention: Collaboration with Benefits for All| 2016
- 13.3.1.1
-
Environmental Sampling and Cultures| 2016
- 13.4.1.1
-
Outbreak Investigations: Laboratory and Epidemiologic Concepts| 2016
- 13.5.1
-
Microbial Strain Typing for Epidemiology and Infection Control| 2016
- 13.6.1.1
-
Surveillance Cultures| 2016
- 13.7.1.1
-
Infection Control in the Laboratory| 2016
- 14.1.1
-
Quality Assessment and Improvement (Quality Assurance)| 2016
- 14.2.1
-
Quality Control| 2016
- 14.3.1
-
Laboratory Records| 2016
- 14.4.1
-
Preparation and Quality Control of Laboratory Water| 2016
- 14.5.1
-
Overview of Individualized Quality Control Plan (IQCP)| 2016
- 15.2.1.1
-
Biological Safety and Biohazard Prevention| 2016
- 15.3.1.1
-
Biohazard Containment| 2016
- 15.4.1.1
-
Laboratory Instrumentation and Equipment| 2016
- 15.5.1.1
-
Special Pathogens and Employee Safety| 2016
- 15.6.1
-
Packing and Shipping Infectious Substances| 2016
- 15.7.1
-
Management of Laboratory Accidents| 2016
- 15.8.1
-
Management of Infectious Waste| 2016
- 15.9.1
-
Risk Assessment| 2016
- 16.1.1
-
General Introduction to Bioterrorism and Emerging Infectious Diseases| 2016
- 16.2.1
-
Levels of Laboratory Safety| 2016
- 16.3.1
-
Packing and Shipping Select Agents| 2016
- 16.4.1
-
Anthrax—Bacillus anthracis| 2016
- 16.5.1
-
Botulinum Toxin—Clostridium Botulinum| 2016
- 16.6.1
-
Brucellosis—Brucella spp.| 2016
- 16.7.1
-
Plague—Yersinia pestis| 2016
- 16.8.1
-
Tularemia—Francisella tularensis| 2016
- 16.9.1
-
Melioidosis (Burkholderia pseudomallei) and Glanders (Burkholderia mallei)| 2016
- 16.10.1
-
Smallpox—Variola Major| 2016
- 16.11.1
-
Novel Influenza Viruses| 2016
- 16.12.1
-
Q Fever–Coxiella burnetii| 2016
- 16.13.1
-
Staphylococcal Enterotoxin B—Staphylococcus aureus| 2016
- 16.14.1
-
Clinical Laboratory Bioterrorism Readiness Plan| 2016
- 16.15.1.1
-
Biochemical Procedures| 2016
- i
-
Front Matter| 2016